References
- Arora T, Padaki R, Liu L, Hamburger AE, Ellison AR, Stevens SR, Differences in binding and effector functions between classes of TNF antagonists. Cytokine 2009;45:124–31.
- Kastbom A, Bratt J, Ernestam S, Lampa J, Padyukov L, Söderkvist P, Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis. Arthritis Rheum 2007;56:448–52.
- Louis EJ, Watier HE, Schreiber S, Hampe J, Taillard F, Olson A, Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohn’s disease: a subanalysis of the ACCENT I study. Pharmacogenet Genomics 2006; 16:911–14.
- Canete JD, Suarez B, Hernandez MV, Sanmartí R, Rego I, Celis R, Influence of variants of Fc{gamma}receptors IIA and IIIA on the ACR and EULAR responses to anti-TNF-alpha therapy in rheumatoid arthritis. Ann Rheum Dis 2009;68:1547–52.
- Braun J, van der Heijde D, Doyle MK, Han C, Deodhar A, Inman R, Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab. Arthritis Rheum 2009;61:1032–6.
- Kim DH, Jung HD, Kim JG, Lee JJ, Yang DH, Park YH, FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma. Blood 2006;108:2720–5.
- Conesa-Zamora P, Santaclara V, Gadea-Ninoles E, Ortiz-Reina S, Perez-Guillermo M. Association of polymorphism in FcGR3A gene and progression of low-grade precursor lesions of cervical carcinoma. Hum Immunol 2010;71:314–17.
- Ho P, Bruce IN, Silman A, Symmons D, Newman B, Young H, Evidence for common genetic control in pathways of inflammation for Crohn’s disease and psoriatic arthritis. Arthritis Rheum 2005;52:3596–602.
- Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997;100:1059–70.
- Kruithof E, Baeten D, De Rycke L, Vandooren B, Foell D, Roth J, Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005;7:R569–80.